MAP2K1 and Alzheimer disease: Thus, the combination of increased MEK1/2 phosphorylation and lower DUSP4 expression caused by disrupted O-GlcNAcylation amplifies ERK1/2 signaling, potentially contributing to AD pathogenesis.